zika
viru
zikv
infect
report
first
time
year
ago
appear
differ
central
western
african
countri
spread
fast
outbreak
brazil
caribbean
year
countri
report
zikv
infect
world
health
organ
declar
public
health
emerg
intern
concern
februari
zikv
transmit
bite
ade
mosquito
aed
africanu
aed
aegypti
aed
luteocephalu
aed
albopictu
detect
bodi
fluid
like
saliva
urin
slight
fever
rash
arthralgia
conjunct
common
symptom
zikv
strong
link
zikv
infect
microcephali
neuron
disord
newborn
infant
women
confirm
march
viral
protein
two
domain
helicas
domain
rna
polymeras
rdrp
domain
vital
viral
polymeras
domain
highli
conserv
activ
site
differ
virus
includ
hepat
c
viru
hcv
west
nile
viru
middl
east
respiratori
syndrom
antivir
activ
differ
nucleotid
inhibitor
studi
rdrp
hcv
sofosbuvir
exampl
success
nucleotid
inhibitor
approv
food
drug
administr
fda
decemb
compound
also
studi
possibl
inhibitor
molecular
model
usual
use
mimic
behavior
molecular
dock
md
import
test
bind
small
molecul
protein
activ
site
virtual
silico
techniqu
use
studi
viral
molecular
dynam
simul
md
offer
mean
studi
protein
dynam
silico
abl
mimic
predict
dynam
properti
protein
addit
suggest
possibl
interact
studi
md
use
mimic
interact
nucleotid
inhibitor
zikv
rdrp
domain
md
perform
predict
model
viral
polymeras
ns
md
carri
ns
test
bind
inhibitor
zikv
rdrp
sequenc
download
nation
center
biotechnolog
protein
homologyanalog
recognit
engin
phyre
use
build
structur
model
zikv
sequenc
dengu
viru
rdrp
domain
structur
use
templat
sequenc
ident
nucleotid
inhibitor
activ
triphosph
form
sketch
optim
use
scigress
optim
done
use
molecular
mechan
forc
field
follow
quantum
mechan
function
supplementari
figur
show
structur
inhibitor
namd
use
perform
md
super
comput
facil
cypru
institut
scienc
project
zikv
model
solvat
explicitli
use
water
two
chlorin
ion
ad
neutral
protein
charg
ph
protein
solvent
system
equilibr
room
temperatur
k
solvent
minim
ps
normal
pressur
temperatur
npt
ensembl
use
relax
system
total
period
ns
normal
volum
temperatur
nvt
ensembl
use
product
run
ns
product
run
box
size
set
base
fluctuat
ns
npt
ensembl
everi
ns
product
run
structur
protein
retriev
dock
studi
therefor
dock
studi
perform
time
differ
dynam
state
differ
conform
retriev
structur
use
check
solvent
access
surfac
area
sasa
radiu
gyrat
r
g
two
paramet
use
check
conform
chang
cours
md
autodock
vina
use
perform
dock
studi
use
default
paramet
protein
treat
rigid
need
test
contribut
dynam
protein
inhibitor
bind
calcul
bind
affin
kcalmol
use
comparison
differ
nucleotid
inhibitor
answer
question
md
perform
cours
md
test
bind
affin
studi
drug
zikv
rdrp
ns
simul
figur
show
averag
bind
affin
gtp
sofosbuvir
ribavirin
zikv
rdrp
ns
md
error
bar
repres
standard
deviat
bind
affin
calcul
everi
ns
md
valu
found
lie
kcalmol
gtp
red
circl
better
neg
bind
affin
compar
ribavirin
shown
superposit
gtp
valu
compound
cpd
cpd
cpd
cpd
green
circl
figur
examin
form
upon
bind
small
molecul
zikv
polymeras
one
find
mode
interact
hcv
polymeras
form
small
molecul
zikv
polymeras
activ
site
aspart
two
amino
acid
activ
site
caviti
result
impli
abil
suggest
compound
compet
gtp
zikv
rdrp
activ
site
entir
period
md
figur
show
exampl
ligand
gtp
bound
zikv
polymeras
ns
ns
b
md
former
arm
extend
distanc
latter
arm
flex
distanc
conform
select
randomli
arm
movement
bind
affin
record
bottom
figur
dramat
chang
bind
affin
arm
movement
also
report
inhibitor
use
supplementari
figur
henc
conclud
arm
movement
contribut
bind
small
molecul
zikv
polymeras
report
author
earlier
studi
show
promis
result
compar
new
suggest
compound
also
promis
averag
bind
affin
zikv
rdrp
compar
drug
figur
upon
bind
suggest
ligand
stop
polymer
process
impair
viru
life
cycl
previou
studi
author
suggest
abil
drug
bind
subsequ
inhibit
zikv
base
structur
similar
hcv
zikv
polymeras
studi
author
simul
dynam
zikv
polymeras
water
ns
result
support
previou
suggest
addit
four
new
compound
introduc
promis
binder
zikv
polymeras
activ
site
base
calcul
bind
affin
hand
arm
movement
occur
ns
affect
bind
small
molecul
futur
work
suggest
test
arm
movement
effect
viral
rna
upon
polymeras
bind
md
carri
supercomput
facil
cypru
institut
scienc
product
run
project
ali
hassanali
appreci
valuabl
discuss
effort
without
work
would
possibl
alaa
ismail
wissam
gawad
ahm
ezat
ahm
gameel
mahmoud
abdelmohsen
mostafa
shaban
appreci
help
support
discuss
aae
perform
calcul
took
part
write
manuscript
wme
revis
manuscript
author
approv
final
version
manuscript
